Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Neuroscience, Inc. )
ClinicalTrials.gov Identifier:
NCT00819000
First received: January 7, 2009
Last updated: January 28, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
No publications provided by Teva Pharmaceutical Industries

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):